JPRN-UMIN000022580已完成未知
Tofogliflozin Reduces 24-h Ambulatory Blood Pressure in inpatients with Type 2 Diabetes and Hypertension - The Influence of Tofogliflozin on 24-h Ambulatory Blood Pressure
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Type 1 diabetes 2) Severe diabetic complications such as ketoacidosis 3) Severe renal dysfunction(estimated glomerular filtration rate [eGFR] < 30 mL/min/) 4) Pregnant or nursing women and those who might be pregnant 5) Chronic heart failure, 6) Haemodialysis, 7) A history of stroke and cardiovascular events, 8) Any patient whom the investigator judged to be inappropriate for this study.
研究者
相似试验
尚未招募
不适用
Effect of Empagliflozin on Ambulatory Blood Pressure Monitoring (ABPM)Diabetics Mellitus HypertensionJPRN-UMIN000022109Department of General Internal Medicine, Saitama Medical University20
进行中（未招募）
1 期
Effect of dapagliflozin on nighttime blood pressure in type 2 diabetesPatients with diabetes and high blood pressureMedDRA version: 20.0Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2017-002125-38-ESM Diagnósticos S.L.225
已完成
不适用
Effects of tofogliflozin treatment on suppression of nocturia and promotion of urinary sodium excretion.JPRN-UMIN000048030Department of Metabolism and Endocrinology, Akita University Graduate School of Medicine36
尚未招募
不适用
Effect of dapagliflozin on blood pressure, cardiac function, visceral fat in type 2 diabetes mellitus patients with hypertension.type 2 diabetesJPRN-UMIN000015203Takeda Hospital Medical Examination Center30
已完成
不适用
Medication induced blood pressure reduction; assessment of cerebral perfusion and cognition in hypertensive elderlyhypertensionhigh blood pressure1000796310057166NL-OMON33986niversitair Medisch Centrum Sint Radboud60